Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 21 Oct 2024
In confirmatory trial, antibody-drug conjugate failed to improve OS versus chemotherapy
Read Full NewsA secondary analysis of the DISTAL trial found endovascular therapy's benefit depended more on stroke severity than on prior thrombolysis treatment.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 23, 2026.
A Canadian cohort found modestly greater preeclampsia risk after donation, though most pregnancies were uncomplicated.
Future pregnancy plans don’t preclude living kidney donation, but candidates should be counseled on gestational hypertension risk.
Sparsentan Lowers Inflammatory, Complement Biomarkers in IgAN
Tegoprubart Improves Quality of Life vs Tacrolimus After Kidney Transplant
1.
CAR T cells improve patients' quality of life: a study
2.
Nasal therapeutic HPV vaccine could prevent cervical cancer
3.
'Ray of hope': New developments in the fight against various cancers.
4.
Why Encouragement May Not Improve Motivation in Depression
5.
Breast Cancer Survivors: Who Benefits From Weight-Loss Meds?
1.
Precision Medicine and Genomics: Harnessing Longitudinal Data Modeling to Decode Cancer Progression
2.
Pediatric Tumor Microenvironment Remodeling During Growth
3.
Developmental Regulation of Pediatric Red-Cell Production
4.
Emerging Pathways in Hematology for Modern Medicine
5.
Risk Assessment of Long-Term Functional Vulnerability After Completion of Cancer Therapy
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
2.
Blood Clotting Disorders Explained
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
4.
Cancer Care: From Awareness to Recovery
5.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge